# Magnetic Microrobots for Drug Delivery: A Review of Fabrication Materials, Structure Designs and Drug Delivery Strategies

**Authors:** Jin Shi, Yanfang Li, Dingran Dong, Junyang Li, Tao Wen, Yue Tang, Qi Zhang, Fei Pan, Liqi Yan, Duanpo Wu, Shaowei Jiang

PMC · DOI: 10.3390/molecules31010086 · Molecules · 2025-12-25

## TL;DR

Magnetic microrobots offer a new way to deliver drugs precisely in the body, with benefits over traditional methods and challenges in moving them to clinical use.

## Contribution

A comprehensive review of fabrication materials, structural designs, and drug delivery strategies for magnetic microrobots.

## Key findings

- Magnetic microrobots enable remote control and precise navigation for improved drug delivery.
- Structural designs and drug release mechanisms enhance therapeutic efficacy and targeting precision.
- Key challenges include biological safety, large-scale production, and navigation in complex environments.

## Abstract

Magnetic microrobots have emerged as a promising platform for drug delivery in recent years. By enabling remotely controlled motion and precise navigation under external magnetic fields, these systems offer new solutions to overcome the limitations of traditional drug delivery nanocarriers, such as inadequate tissue penetration and heterogeneous biodistribution. Over the past few years, significant advancements have been made in the structural design of magnetic microrobots, as well as in drug loading techniques and stimuli-responsive drug release mechanisms, thereby demonstrating distinct advantages in enhancing therapeutic efficacy and targeting precision. This review provides a comprehensive overview of magnetic drug delivery microrobots, which are categorised into biomimetic structural, bio-templated and advanced material-based types, and introduces their differences in propulsion efficiency and biocompatibility. Additionally, drug loading and release strategies are summarised, including physical adsorption, covalent coupling, encapsulation, and multistimuli-responsive mechanisms such as pH, enzyme activity and thermal triggers. Overall, these advancements highlight the significant potential of magnetic microrobots in targeted drug delivery and emphasise the key challenges in their clinical translation, such as biological safety, large-scale production and precise targeted navigation within complex biological environments.

## Full-text entities

- **Genes:** MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, NR3C2 (nuclear receptor subfamily 3 group C member 2) [NCBI Gene 4306] {aka MCR, MLR, MR, NR3C2VIT}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}
- **Diseases:** glioma (MESH:D005910), injury to (MESH:D014947), osteosarcoma (MESH:D012516), inflammation (MESH:D007249), pancreatic cancer (MESH:D010190), T24 tumour (MESH:D009369), deafness (MESH:D003638), hyperthermia (MESH:D005334), hearing loss (MESH:D034381), AMOA (MESH:D010003), hemolytic (MESH:D006461), haematological toxicity (MESH:D006402), ototoxicity (MESH:D006311), cytotoxic (MESH:D064420), triple-negative breast cancer (MESH:D064726), ocular diseases (MESH:D005128), liver cancer (MESH:D006528), solid (MESH:D018250), GBM (MESH:D005909), bladder cancer (MESH:D001749)
- **Chemicals:** gold (MESH:D006046), CaCO3 (MESH:D002119), metal (MESH:D008670), PEGDA (MESH:C437167), Sodium alginate (MESH:D000464), cypate (MESH:C000604523), chitosan (MESH:D048271), magnetite (MESH:D052203), hesperidin (MESH:D006569), quercetin (MESH:D011794), CPT-11 (MESH:D000077146), ALA (MESH:D008063), polysaccharide (MESH:D011134), nickel (MESH:D009532), polypyrrole (MESH:C067635), MOF (MESH:D000073396), carbon (MESH:D002244), polymer (MESH:D011108), ester (MESH:D004952), amide (MESH:D000577), ASA (MESH:D001241), N-hydroxysuccinimide (MESH:C001426), CCK-8 (MESH:D012844), TSA (MESH:C021751), water (MESH:D014867), 5-FU (MESH:D005472), Fe (MESH:D007501), rhodium (MESH:D012238), acetic acid (MESH:D019342), THPP (MESH:C014870), biotin (MESH:D001710), iron oxide (MESH:C000499), PDA (MESH:C568283), curcumin (MESH:D003474), PEI@DOX (-), cisplatin (MESH:D002945), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (MESH:C000613388), mitomycin (MESH:D016685), Ro-3306 (MESH:C512984), DOX (MESH:D004317), silica (MESH:D012822), TMZ (MESH:D000077204), indomethacin (MESH:D007213), PFD (MESH:C093844), indocyanine green (MESH:D007208), fatty acid (MESH:D005227), PCL (MESH:C016240), amine (MESH:D000588), PNAGA (MESH:C000591468), iodine (MESH:D007455), PFH (MESH:C078626), pyrrole (MESH:D011758), hydrogen (MESH:D006859), MXene (MESH:C000723374), PLGA (MESH:D000077182), PNIPAM (MESH:C052970), PBS (MESH:D007854), 5,10,15,20-Tetrakis(4-hydroxyphenyl)porphyrin (MESH:C051232), aminopropyltrimethoxysilane (MESH:C529884), GEM (MESH:D000093542)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Chlorella [taxon 114055], Spirulina (suborder) [taxon 551299], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], PX clade (clade) [taxon 569578]
- **Cell lines:** HuCCT1 — Homo sapiens (Human), Intrahepatic cholangiocarcinoma, Cancer cell line (CVCL_0324), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12787128/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12787128/full.md

## References

154 references — full list in the complete paper: https://tomesphere.com/paper/PMC12787128/full.md

---
Source: https://tomesphere.com/paper/PMC12787128